Transgenic Host Cells Reconstructing the Salidroside Biosynthetic Pathway

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The commercial production of salidroside, a valuable bioactive compound from the Rhodiola genus, is hindered by a lengthy purification process from native plants, leading to overharvesting and potential extinction of these plants, and existing biosynthetic pathways in heterologous hosts are incomplete.

Innovation Solution

Elucidation of the Rhodiola salidroside biosynthetic pathway through transcriptomics and metabolomics, identifying key enzymes like 4-hydroxyphenylacetaldehyde synthase (4HPAAS), 4-hydroxyphenylacetaldehyde reductase (4HPAR), and tyrosol:UDP-glucose 8-O-glucosyltransferase (T8GT), enabling their expression in yeast and plant hosts to produce salidroside and icariside D2.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If salidroside is obtained through purification from native Rhodiola plants, then pure salidroside is obtained, but the process is lengthy and leads to overharvesting of plants

Engineering Contradiction:

Improvepurity of salidrosideVSAvoidlength of purification process

Core Design Contradiction:

Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent creates a synthetic copy of the salidroside biosynthetic pathway by expressing plant enzymes (4HPAAS, 4HPAR, T8GT) in heterologous host cells. This copying approach allows production of salidroside without harvesting native plants, eliminating the time-consuming purification process while maintaining product purity.

Inventive Principle:

Principle #26Copying

Solution Approach 2:

The patent introduces intermediary enzymes (4HPAAS, 4HPAR, T8GT) that mediate the conversion of tyrosine to salidroside in heterologous hosts. These intermediary biological components enable direct production in cell cultures, bypassing the need for plant extraction and lengthy purification.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Manufacturing precision

If salidroside is obtained through purification from native plants, then pure salidroside is obtained, but native plant species are depleted and face extinction

Engineering Contradiction:

Improvepurity of salidrosideVSAvoiddepletion of native plant species

Core Design Contradiction:

Manufacturing precisionVSLoss of substance

Solution Approach 1:

The patent copies the salidroside biosynthetic pathway into heterologous host cells, enabling production without depleting native Rhodiola plants. This approach maintains product purity while preserving native plant species from extinction.

Inventive Principle:

Principle #26Copying

Solution Approach 2:

The heterologous host cells are engineered to self-produce salidroside through the introduced biosynthetic pathway, eliminating the need to extract the compound from native plants. The system serves itself by converting tyrosine to salidroside using the expressed enzymes.

Inventive Principle:

Principle #25Self-service

3Productivity

If existing biosynthetic pathways are used in heterologous hosts, then production can be achieved, but the pathways are incomplete

Engineering Contradiction:

Improveproduction of salidrosideVSAvoidcompleteness of biosynthetic pathway

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the salidroside biosynthetic pathway into three discrete enzymatic steps (4HPAAS, 4HPAR, T8GT) and expresses them separately in heterologous hosts. This segmentation allows for systematic construction of the complete pathway, achieving both productivity and pathway completeness.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent merges multiple plant genes (4HPAAS, 4HPAR, T8GT) into a functional biosynthetic pathway in heterologous host cells. By combining these genes with appropriate promoters and regulatory elements, the complete pathway is reconstituted, enabling production of salidroside and icariside D2.

Inventive Principle:

Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates sustainable and cost-effective production of salidroside and icariside D2 in heterologous hosts, overcoming the limitations of traditional purification methods and preserving native plant species.

Implementation Method 1

a pyridoxal phosphate (PLP)-dependent 4-hydroxyphenylacetaldehyde synthase (4HPAAS) that directly converts tyrosine to 4-HPAA

Methodology Applied

Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 2

Genes encoding the subsequent 4-HPAA reductase (4HPAR)

Methodology Applied

Scientific EffectEnzymatic reduction: Enzyme

Implementation Method 3

tyrosol:UDP-glucose 8-O-glucosyltransferase (T8GT)

Methodology Applied

Scientific EffectEnzymatic glycosylation: Enzyme

Data Source

PatentUS12385055B2Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2

Publication Date: 2025.08.12 WHITEHEAD INST FOR BIOMEDICAL RES

AI summary

Transgenic host cells, vectors useful for making transgenic host cells, and kits useful for making transgenic host cells are described. Also described are transgenic plants. In some embodiments, transgenic host cells express a 4-hydroxyphenylacetaldehyde synthase (4HPAAS). In some embodiments, transgenic host cells express a tyrosol:UDP-glucose 8-O-glucosyltransferase (T8GT). The transgenic host cells are useful for biosynthesis of one or more of salidroside, icariside D2, tyrosol, and 4-hydroxypenylacetaldehyde.